Carter Coberley, PhD

home / authors / carter-coberley-phd

Articles

Site Logo
January 20th 2016

Impact of a Scalable Care Transitions Program for Readmission Avoidance

Brent Hamar, DDS, MPH Elizabeth Y. Rula, PhD Aaron R. Wells, PhD Carter Coberley, PhD James E. Pope, MD Daniel Varga, MD

The 30-day readmission risk was reduced 25% by a collaborative program model employing discharge planning and telephonic follow-up for high-risk patients with CMS penalty diagnoses.

Site Logo
April 1st 2007

Impact of Telephonic Interventions on Glycosylated Hemoglobin and Low-density Lipoprotein Cholesterol Testing

Carter Coberley, PhD Brent Hamar, DDS, MPH Bill Gandy, EdD Patty Orr, RN, EdD Sadie Coberley, PhD Matthew McGinnis, BS Laurel Hudson, RN, MSN Sam Forman, MD, MPH, MBA Dexter Shurney, MD, MPH, MBA James Pope, MD

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Long-Term Follow-Up from CheckMate 9LA at ASCO 2024
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Insights from the TROPION-Lung05 Trial at ASCO 2024
Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School
Published: July 24th 2024 | Updated: July 27th 2024
Examining Trends, Future Directions in AI and Health Care
Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD
Alfred L. Garfall, MD, an expert on multiple myeloma
Published: July 24th 2024 | Updated: July 27th 2024
Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo